Targeted Therapies & Future Directives: RNAi Drug Delivery Market
According to Inkwood Research, the global RNA interference (RNAi) drug delivery market is expected to grow at a CAGR of 22.24% over the forecast period 2024–2032. Innovations in pharmaceuticals have propelled RNA interference (RNAi) drug delivery to the forefront of oncology treatment. RNAi utilizes the body’s molecular mechanisms to silence disease-causing genes, offering precise therapeutic…
Details



